Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Ando · SciRah

Researcher profile · Semantic Scholar

Y. Ando

Share profile

Y. Ando — researcher profile on SciRah

h-index: 39
Works: 281
Citations: 5,218

Most-cited papers

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study
Tomoko Kobayashi, Shintaro Iwama, Yoshinori Yasuda, N. Okada +20 more
2018Journal of the Endocrine Society171 citations Open access
Semantic Scholar
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study
Tomoko Kobayashi, Shintaro Iwama, Yoshinori Yasuda, N. Okada +23 more
2020Journal for ImmunoTherapy of Cancer104 citations Open access
Semantic Scholar
Guidelines for treatment of renal injury during cancer chemotherapy 2016
S. Horie, M. Oya, M. Nangaku, Y. Yasuda +13 more
2017Clinical and Experimental Nephrology75 citations Open access
Semantic Scholar
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study
N. Okada, Shintaro Iwama, Takayuki Okuji, Tomoko Kobayashi +29 more
2020British Journal of Cancer66 citations Open access
Semantic Scholar
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies
Kazuyuki Mizuno, Takanori Ito, M. Ishigami, Yoji Ishizu +19 more
2020Journal of gastroenterology66 citations Open access
Semantic Scholar
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors
A. Wick, O. Bähr, M. Schuler, K. Rohrberg +27 more
2021Clinical Cancer Research57 citations
Semantic Scholar
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
Yuki Miyai, D. Sugiyama, T. Hase, N. Asai +12 more
2022Life Science Alliance51 citations Open access
Semantic Scholar
Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors
Y. Ando, S. Iwasa, S. Takahashi, H. Saka +5 more
2019Cancer Science44 citations Open access
Semantic Scholar
Reporting harms more transparently in trials of cancer drugs
B. Gyawali, T. Shimokata, K. Honda, Y. Ando
2018British medical journal35 citations Open access
Semantic Scholar
Guidelines for clinical evaluation of anti‐cancer drugs
H. Minami, N. Kiyota, S. Kimbara, Y. Ando +14 more
2021Cancer Science33 citations Open access
Semantic Scholar
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
Takanori Ito, M. Ishigami, Takafumi Yamamoto, Kazuyuki Mizuno +20 more
2021Hepatology International32 citations Open access
Semantic Scholar
Increased risk of thyroid dysfunction by PD-1 and CTLA-4 blockade in patients without thyroid autoantibodies at baseline.
Shintaro Iwama, Tomoko Kobayashi, Yoshinori Yasuda, Takayuki Okuji +38 more
2021Journal of Clinical Endocrinology and Metabolism30 citations Open access
Semantic Scholar
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
Kenta Yamada, T. Sawada, M. Nakamura, T. Yamamura +19 more
2021World Journal of Gastroenterology28 citations Open access
Semantic Scholar
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
S. Yamada, T. Fujii, Y. Yokoyama, H. Kawashima +16 more
2018Cancer Chemotherapy and Pharmacology26 citations Open access
Semantic Scholar
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
P. Schöffski, N. Concin, C. Suárez, V. Subbiah +10 more
2021Oncology Research and Treatment24 citations
Semantic Scholar
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
H. Tsukuura, M. Miyazaki, T. Morita, M. Sugishita +9 more
2018The Oncologist22 citations Open access
Semantic Scholar
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
Y. Nishida, Shunsuke Hamada, H. Urakawa, Kunihiro Ikuta +6 more
2020Cancer Science21 citations Open access
Semantic Scholar
Abstract CT171: Phase I study of BLZ945 alone and with spartalizumab (PDR001) in patients (pts) with advanced solid tumors
Chia-Chi Lin, M. Gil-Martin, T. Bauer, A. Naing +9 more
2020Tumor Biology21 citations
Semantic Scholar
Elevated TSH level, TgAb and prior use of ramucirumab or TKIs as risk factors for thyroid dysfunction in PD-L1 blockade.
Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, Yoshinori Yasuda +20 more
2022Journal of Clinical Endocrinology and Metabolism20 citations Open access
Semantic Scholar
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective
Satoshi Nishiwaki, Y. Ando
2021Frontiers in Medicine18 citations Open access
Semantic Scholar
Gap between pediatric and adult approvals of molecular targeted drugs
Satoshi Nishiwaki, Y. Ando
2020Scientific Reports18 citations Open access
Semantic Scholar
Experiences and hidden needs of older patients, their families and their physicians in palliative chemotherapy decision-making: a qualitative study.
Rie Tsuboi, M. Sugishita, Y. Hirakawa, Y. Ando
2020Japanese Journal of Clinical Oncology17 citations
Semantic Scholar
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study).
G. Nakayama, A. Mitsuma, Yuki Sunagawa, K. Ishigure +20 more
2018The Oncologist17 citations Open access
Semantic Scholar
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
Y. Nishida, H. Urakawa, R. Nakayama, E. Kobayashi +14 more
2020International Journal of Cancer16 citations Open access
Semantic Scholar
Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer
K. Honda, Kyosuke Takeshita, K. Murotani, A. Mitsuma +5 more
2017Breast Cancer14 citations
Semantic Scholar
The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)
G. Nakayama, K. Ishigure, H. Yokoyama, K. Uehara +17 more
2017BMC Cancer14 citations Open access
Semantic Scholar
Me ﬂ in-positive cancer-associated ﬁ broblasts enhance tumor response to immune checkpoint blockade
Yuki Miyai, D. Sugiyama, T. Hase, N. Asai +12 more
202213 citations
Semantic Scholar
Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury
Takafumi Yamamoto, H. Morooka, Takanori Ito, M. Ishigami +13 more
2022Journal of Gastroenterology and Hepatology12 citations Open access
Semantic Scholar
Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer
H. Minami, Y. Ando, K. Tamura, T. Tajima +1 more
2020Anticancer Research12 citations Open access
Semantic Scholar
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan
Sachi Morita, T. Kikumori, Nobuyuki Tsunoda, Takahiro Inaishi +11 more
2018International Journal of Clinical Oncology12 citations
Semantic Scholar
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Y. Ando, Hiroyuki Nishiyama, H. Shimodaira, Nao Takano +20 more
2023International Journal of Clinical Oncology11 citations
Semantic Scholar
A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors
Sachi Morita, H. Minami, A. Mitsuma, Masanori Toyoda +2 more
2022Asia-Pacific Journal of Clinical Oncology11 citations
Semantic Scholar
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review
O. Maeda, F. Ohka, S. Maesawa, A. Matsuoka +8 more
2020Nagoya journal of medical science9 citations
Semantic Scholar
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis
Takafumi Yamamoto, Kazuyuki Mizuno, Takanori Ito, S. Yokoyama +18 more
2023Investigational new drugs8 citations Open access
Semantic Scholar
A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in Japan.
A. Matsuoka, T. Shimazu, Masahiro Takahashi, F. Nagashima +3 more
2022Journal of Geriatric Oncology8 citations
Semantic Scholar
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study).
G. Nakayama, Nao Takano, H. Taniguchi, K. Ishigure +26 more
2020European Journal of Cancer8 citations
Semantic Scholar
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Y. Nishida, H. Urakawa, R. Nakayama, T. Ozaki +6 more
20208 citations
Semantic Scholar
Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
O. Maeda, Y. Ando
2019World Journal of Gastrointestinal Oncology8 citations Open access
Semantic Scholar
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study
O. Maeda, A. Matsuoka, R. Miyahara, K. Funasaka +6 more
2017World Journal of Gastroenterology8 citations Open access
Semantic Scholar
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study
Nao Takano, S. Yamada, A. Hirakawa, Y. Yokoyama +19 more
2019Nagoya journal of medical science7 citations
Semantic Scholar
Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study
O. Maeda, M. Fukaya, M. Koike, K. Miyata +5 more
2022Asia-Pacific Journal of Clinical Oncology6 citations
Semantic Scholar
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
Yuko Takano, S. Furune, Yuki Miyai, Sachi Morita +6 more
2021International Cancer Conference Journal6 citations Open access
Semantic Scholar
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
S. Furune, C. Kondo, Yuko Takano, T. Shimokata +4 more
2021International Cancer Conference Journal6 citations Open access
Semantic Scholar
Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5’-Deoxy-5-fluorocytidine, and Creatinine Clearance
Takahiro Inaishi, K. Fujita, Natsumi Matsumoto, T. Shimokata +5 more
2020In Vivo6 citations Open access
Semantic Scholar
Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study
H. Urakawa, Y. Ando, T. Hase, T. Kikumori +8 more
2019International Journal of Cancer6 citations Open access
Semantic Scholar
Detection of bacteria in blood circulation in patients receiving cancer chemotherapy
A. Ota, Sachi Morita, A. Matsuoka, T. Shimokata +5 more
2019International Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft‐tissue sarcoma
K. Yonemori, M. Kodaira, T. Satoh, T. Kudo +9 more
2018Cancer Science6 citations Open access
Semantic Scholar
Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer
Takahiro Hatta, T. Hase, T. Hara, T. Kimura +16 more
2023Cancer Medicine5 citations Open access
Semantic Scholar
Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies
H. Minami, T. Doi, Masanori Toyoda, Y. Imamura +10 more
2020Cancer Science5 citations Open access
Semantic Scholar
Influence of tumor size and Eastern Cooperative Oncology Group performance status (ECOG PS) at baseline on patient (pt) outcomes in lenvatinib-treated radioiodine-refractory differentiated thyroid cancer (RR-DTC).
L. Wirth, S. Leboulleux, N. Kiyota, M. Tahara +14 more
2019Journal of Clinical Oncology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Maeda×15
Invite
O. Maeda — researcher profile on SciRah
T. Hase×14
Invite
T. Hase — researcher profile on SciRah
T. Shimokata×13
Invite
T. Shimokata — researcher profile on SciRah
Y. Kodera×11
Invite
Y. Kodera — researcher profile on SciRah

×10

Invite

M. Ando — researcher profile on SciRah

Invite

A. Mitsuma — researcher profile on SciRah

N. Hashimoto×8

Invite

N. Hashimoto — researcher profile on SciRah

Invite

M. Akiyama — researcher profile on SciRah

H. Kawashima×8

Invite

H. Kawashima — researcher profile on SciRah

Invite

K. Yokota — researcher profile on SciRah

Takanori Ito×6

Invite

Takanori Ito — researcher profile on SciRah

Invite

M. Ishigami — researcher profile on SciRah